GLP-1 RAs and rare, but severe, eye disorders
AustraliaGLP-1 RAs and rare, but severe, eye disorders
Recalling Firm: TGA
Reason for Recall / Hazard
Product warnings across the GLP-1 RA class of medicines have been updated due to the potential for these products to cause a rare, but severe, form of eye disorder....
Product Description & Identification
Product warnings across the GLP-1 RA class of medicines have been updated due to the potential for these products to cause a rare, but severe, form of eye disorder.
Affected Products
GLP-1 RAs and rare, but severe, eye disorders
Additional Source Details
| Field | Value |
|---|---|
| Guid › #text | https://www.tga.gov.au/node/567261 |
| Guid › @ is Perma Link | true |
| Link | https://www.tga.gov.au/safety/safety-monitoring-and-information/safety-alerts/glp-1-ras-and-rare-severe-eye-disorders |
| Pub Date | Thu, 23 Jul 2026 00:00:00 +1000 |
| Extracted category | drugs |
Overview
- Recalling FirmTGA
- Risk LevelMedicines Safety Alert
- DistributionAustralia
📢 Share Warning
Alert family and friends to keep them safe. Copy this quick alert message:
🚨 SAFETY ALERT: TGA - GLP-1 RAs and rare, but severe, eye disorders Check if your household is affected: https://therecallfile.com/recalls/glp-1-ras-and-rare-but-severe-eye-disorders/AU-TGA-567261
Join Alertlist
Get instant email updates whenever critical safety recalls like this are published.
Related Recalls
UKClass 4 Medicines Defect Notification: Neuraxpharm UK Ltd, Tuzulby prolonged-release chewable tablets, EL(26)A/36
Class 4 Medicines Defect Notification: Neuraxpharm UK Ltd, Tuzulby prolonged-release chewable tablets, EL(26)A/36
Neuraxpharm UK Ltd has informed the MHRA of missing safety information in the Patient Information Leaflet (PIL) and Summary of Product Characteristics (SmPC) for certain batches of Tuzulby prolonged r...
UKClass 4 Medicines Defect Notification: Macarthys Laboratories Ltd T/A Martindale Pharma, Xaggitin XL Prolonged-release Tablets, EL(26)A/35
Class 4 Medicines Defect Notification: Macarthys Laboratories Ltd T/A Martindale Pharma, Xaggitin XL Prolonged-release Tablets, EL(26)A/35
Macarthys Laboratories Ltd T/A Martindale Pharma has notified the MHRA of a manufacturing issue impacting several batches of Xaggitin XL Prolonged-release Tablets, due to the occurrence of incorrect t...
FDA DrugsMethohexital Sodium for Injection, USP 500 mg Multiple Dose Vial, Rx Only, Manufactured by: OneSource Specialty, Pharma Limited, Bengaluru - 561 203, India, Manufactured for: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816, NDC 23155-893-31
Methohexital Sodium for Injection, USP 500 mg Multiple Dose Vial, Rx Only, Manufactured by: OneSource Specialty, Pharma Limited, Bengaluru - 561 203, India, Manufactured for: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816, NDC 23155-893-31
Failed Impurities/Degradation Specifications